On Tuesday, Shares of Abbott Laboratories (NYSE:ABT), subtract -5.38% and closed at $41.16 in the last trading session. The last trading range of the stock ranges between $41.02 and $43.27. The company’s Market capitalization is $61.25 Billion with the total Outstanding Shares of 1.47 Billion. During the 52-week trading session the minimum price at which share price traded, registered at $36.00 and reached to max level of $46.38. Abbott (ABT) recently declared that the U.S. Food and Drug Administration (FDA) has approved the company’s FreeStyle Libre Pro system, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals to use with their patients with diabetes.
FreeStyle Libre Pro system is designed to empower healthcare professionals to provide better diabetes administration for diabetes patients. The system provides healthcare professionals with a visual snapshot of glucose data, known as the Ambulatory Glucose Profile (AGP), giving a more simplified and clear overview of not only glucose levels, but also patterns and trends within those levels. This valuable information assists healthcare professionals make better, customized treatment decisions for their patients – and for a significantly lower cost than other professional CGM products availablei.
On nearly a daily basis, Eugene E. Wright, Jr., M.D. of Duke Southern Regional Area Health Education Center in Fayetteville, N.C., finds it challenging to effectively treat his patients with diabetes when it comes to decisions around insulin, nutrition and medication. “My patients are often out of range, because of inconsistent self-monitoring and insufficient data from traditional glucose meters that are unable to provide a full view of their glucose levels.”
Nike Inc (NYSE:NKE), jumped 0.06% and closed at $51.82 in the last trading session. The last trading range of the stock ranges between $51.52 and $52.25. The company’s Market capitalization is $86.95 Billion with the total Outstanding Shares of 1.33 Billion. During the 52-week trading session the minimum price at which share price traded, registered at $51.47 and reached to max level of $68.19. NIKE, Inc. (NKE) declared recently that Tom Peddie becomes the new VP, GM of North America, succeeding Joaquin Hidalgo, who has served in this role since July 2013 and will be taking a leave of absence to focus on his health. This change is effective right away.
Peddie, a 26-year Nike veteran, has held senior administration roles across Nike, counting VP North America Sales and VP Global Sales. He was formerly VP, GM of Emerging Markets and joined the North America team earlier this year as VP, GM of Integrated Marketplace, where he has led Nike’s holistic integrated market strategy in North America.
“Tom is a strong leader with a deep understanding of our consumer and the integrated marketplace,” said Elliott Hill, President of Geographies and Sales, Nike Brand. “He has proven time and again his ability to lead teams toward continued and profitable long-term growth and we look forward to his leadership in this important geography.”